Daily Market Reports | Mar 04 2026
This story features AMA GROUP LIMITED, and other companies.
For more info SHARE ANALYSIS: AMA
The company is included in ALL-ORDS
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
AMA AMI AR1 ARB ASG AUB BC8 CUP CXL EMR EOL IDX (2) INA IOD IRE KCN KLS MGH MMS MND MXI NAN NDO NEC NIC OCL PLY PPS PRN REG REH SKC SYL THL TLX TYR VAU VGL VYS WPR
AMA AMA GROUP LIMITED
Automobiles & Components – Overnight Price: $0.63
Canaccord Genuity rates ((AMA)) as Buy (1) –
AMA Group delivered an interim result that was in line with estimates and guidance has been maintained. Canaccord Genuity observes the result was underpinned by significant improvement in the financial performance of AMA Collison as well as the contribution from the ACM Parts business.
The improvement in AMA Collision offset the expected pullback in Capital SMART as it cycled elevated repair volumes and incentives in the prior corressponding half.
Modest downward revisions are made to EBITDA forecasts but the D&A assumption has been lifted and that will have a more significant impact at the net profit level, the broker points out. Buy rating. Target is reduced to $1.23 from $1.50.
This report was published on February 25, 2026.
Target price is $1.23 Current Price is $0.63 Difference: $0.6
If AMA meets the Canaccord Genuity target it will return approximately 95% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 126.00.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 3.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.58.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
AMI AURELIA METALS LIMITED
Gold & Silver – Overnight Price: $0.31
Moelis rates ((AMI)) as Buy (1) –
The first half result from Aurelia Metals was largely pre-reported and Moelis makes no material changes to estimates. The broker believes the stock could become one of the “go to” small base metal producers on the ASX.
The stock may be recovering from a material downgrade in the middle of 2025 but the broker assesses the business is in “good health”.
Going forward, buoyant metal prices are likely to be sufficient to ensure the company can sustain its balance sheet position and Moelis retains a Buy rating. Target is $0.43.
This report was published on February 27, 2026.
Target price is $0.43 Current Price is $0.31 Difference: $0.12
If AMI meets the Moelis target it will return approximately 39% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of 4.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.38.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 0.00 cents and EPS of 5.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 5.96.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
AR1 AUSTRAL RESOURCES AUSTRALIA LIMITED
Copper – Overnight Price: $0.10
Shaw and Partners rates ((AR1)) as Buy, High Risk (1) –
Austral Resources has raised $65m at 9cps cornerstoned by the QIC Critical Minerals Fund.
Proceeds will be used to repay the $18m Glencore debt and support a dual-track strategy targeting 50ktpa copper production by late 2027, explains Shaw and Partners.
Austral will now hold $97m in pro-forma cash and become debt-free, highlights the broker.
Management will undertake a two-year refurbishment of the Rocklands concentrator for a mid-2027 restart, including a SAG mill upgrade to lift throughput to 500tph from 210tph.
Austral reported a -$6.14m loss from continuing operations in 2025, though disposal of Anthill’s -$28.6m net liabilities delivered a $11.9m statutory profit.
Shaw updates its earnings forecasts primarily for copper price changes. The target falls to $0.42 from $0.50. Buy, High Risk rating maintained.
This report was published on March 3, 2026.
Target price is $0.42 Current Price is $0.10 Difference: $0.325
If AR1 meets the Shaw and Partners target it will return approximately 342% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 10.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 0.88.
Forecast for FY27:
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 156.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 0.06.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ARB ARB CORPORATION LIMITED
Automobiles & Components – Overnight Price: $24.03
Canaccord Genuity rates ((ARB)) as Hold (3) –
ARB Corp posted first half underlying pre-tax profit of $58m, in line with the prior update. Canaccord Genuity notes operating cash flow was in line with earnings and the balance sheet remains in a net cash position.
The main negative was an effective downgrade to second half forecasts. The broker suspects consensus expectations for growth in outer years are unrealistic.
While significant growth in US export revenue is one factor that has sparked investor interest for some time the broker emphasises that Australia is the “engine”. Conditions are expected to remain difficult in the near term.
Hold rating unchanged. Target is reduced to $22.90 from $29.60.
This report was published on February 24, 2026.
Target price is $22.90 Current Price is $24.03 Difference: minus $1.13 (current price is over target).
If ARB meets the Canaccord Genuity target it will return approximately minus 5% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $28.06, suggesting upside of 17.6%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 64.00 cents and EPS of 106.00 cents.
At the last closing share price the estimated dividend yield is 2.66%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 22.67.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 106.2, implying annual growth of -9.8%.
Current consensus DPS estimate is 71.1, implying a prospective dividend yield of 3.0%.
Current consensus EPS estimate suggests the PER is 22.5.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 66.00 cents and EPS of 110.00 cents.
At the last closing share price the estimated dividend yield is 2.75%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.85.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 118.2, implying annual growth of 11.3%.
Current consensus DPS estimate is 70.3, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 20.2.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ASG AUTOSPORTS GROUP LIMITED
Automobiles & Components – Overnight Price: $2.86
Moelis rates ((ASG)) as Buy (1) –
Autosports Group will acquire Solitaire Automotive Group for $50m, one of Adelaide’s established luxury dealerships.
As per Moelis’ commentary, this marks the company’s entry into the South Australian market with Solitaire having a unique position as a sole retailer in South Australia for most of its portfolio.
Moelis calculates Solitaire generates pre-tax profit margins in line with the Autosports margin, implying an acquisition multiple of 5-6x. Buy rating retained with a target of $4.91.
This report was published on February 26, 2026.
Target price is $4.91 Current Price is $2.86 Difference: $2.05
If ASG meets the Moelis target it will return approximately 72% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 10.10 cents and EPS of 26.10 cents.
At the last closing share price the estimated dividend yield is 3.53%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.96.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 12.50 cents and EPS of 32.00 cents.
At the last closing share price the estimated dividend yield is 4.37%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.94.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
AUB AUB GROUP LIMITED
Insurance – Overnight Price: $23.90
Jarden rates ((AUB)) as Overweight (2) –
AUB Group’s 1H26 earnings (EBIT) of $90.4m was in line with pre-guidance, with operating earnings 3% ahead of the consensus expectation, observes Jarden. EPS met forecasts due to higher corporate, interest and minority interest costs, explain the analysts.
Revenue was broadly in line with the broker, with growth driven by Bizcover and Agencies, while New Zealand declined -3.5% and delivered a -470bps margin contraction on the prior year.
FY26-28 EPS forecasts are trimmed by between -2-6% on New Zealand execution risk and higher funding costs, despite margin strength elsewhere and limited AI exposure, the analysts explain.
Jarden lowers its target price to $34.60 from $38.20 and reiterates an Overweight rating.
This report was published on February 24, 2026.
Target price is $34.60 Current Price is $23.90 Difference: $10.7
If AUB meets the Jarden target it will return approximately 45% (excluding dividends, fees and charges).
Current consensus price target is $33.80, suggesting upside of 44.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 97.00 cents and EPS of 185.30 cents.
At the last closing share price the estimated dividend yield is 4.06%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.90.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 183.2, implying annual growth of 18.6%.
Current consensus DPS estimate is 96.4, implying a prospective dividend yield of 4.1%.
Current consensus EPS estimate suggests the PER is 12.7.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 111.00 cents and EPS of 203.70 cents.
At the last closing share price the estimated dividend yield is 4.64%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.73.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 197.9, implying annual growth of 8.0%.
Current consensus DPS estimate is 104.6, implying a prospective dividend yield of 4.5%.
Current consensus EPS estimate suggests the PER is 11.8.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BC8 BLACK CAT SYNDICATE LIMITED
Gold & Silver – Overnight Price: $1.55
Moelis rates ((BC8)) as Buy (1) –
Black Cat Syndicate produced “messy” first half accounts, Moelis asserts, although the numbers will look cleaner going forward as the company transitions to a more conventional operating model.
No material changes are made to estimates arising from the result except for an uplift in D&A run rates. The investment view is unchanged and going forward the business will operate its own mines and process its own ore.
The broker recommends investors focus on the compelling domestic gold play. A Buy rating is maintained and the target is lifted to $1.85 from $1.80.
This report was published on February 27, 2026.
Target price is $1.85 Current Price is $1.55 Difference: $0.295
If BC8 meets the Moelis target it will return approximately 19% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of 16.40 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.48.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 0.00 cents and EPS of 31.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 5.00.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CUP COUNT LIMITED
Commercial Services & Supplies – Overnight Price: $1.11
Canaccord Genuity rates ((CUP)) as Buy (1) –
Count delivered first half revenue that was ahead of estimates and Canaccord Genuity notes the strong result flowed through all subsequent lines. Strength was particularly evident in the wealth division where operating leverage is enhanced.
The broker envisages continued double-digit growth, amid structural drivers as a backdrop to a well-established platform. The broker raises FY26 estimates for EPS by 6.6% and FY27 by 4.6%. Buy rating maintained. Target rises to $1.50 from $1.35.
This report was published on February 24, 2026.
Target price is $1.50 Current Price is $1.11 Difference: $0.39
If CUP meets the Canaccord Genuity target it will return approximately 35% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 5.00 cents and EPS of 9.80 cents.
At the last closing share price the estimated dividend yield is 4.50%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.33.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 5.75 cents and EPS of 10.50 cents.
At the last closing share price the estimated dividend yield is 5.18%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.57.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CXL CALIX LIMITED
Industrial Sector Contractors & Engineers – Overnight Price: $0.82
Canaccord Genuity rates ((CXL)) as Buy (1) –
Calix has made a series of positive announcements with its first half result, Canaccord Genuity observes, declaring the business will operate on a cash flow neutral position in 2026.
The broker found momentum in Magnesia impressive while a possible catalyst looms with external investment in Zesty.
Cash flow is the most important change to forecasts and the broker’s revised estimates envisage the business exiting 2026 with around $24m net cash, compared to previous forecasts of $5m.
Buy rating retained. Target rises to $2.40 from $2.15.
This report was published on February 25, 2026.
Target price is $2.40 Current Price is $0.82 Difference: $1.58
If CXL meets the Canaccord Genuity target it will return approximately 193% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 8.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 10.12.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 5.90 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 13.90.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
EMR EMERALD RESOURCES NL
Gold & Silver – Overnight Price: $6.88
Canaccord Genuity rates ((EMR)) as Hold (3) –
Emerald Resources delivered first half results where the reported EBITDA was 2% above Canaccord Genuity’s estimates amid a working capital adjustment.
Revenue of $253m came from the sale of 44,000 ounces from the Okvau gold mine in Cambodia.
The company finished the first half with cash and bullion of $335m, up 49% over the half. The broker maintains a Hold rating on valuation grounds and an unchanged target of $7.35.
This report was published on February 24, 2026.
Target price is $7.35 Current Price is $6.88 Difference: $0.47
If EMR meets the Canaccord Genuity target it will return approximately 7% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 40.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.20.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 12.00 cents and EPS of 62.00 cents.
At the last closing share price the estimated dividend yield is 1.74%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.10.
Market Sentiment: -1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
EOL ENERGY ONE LIMITED
Energy Sector Contracting – Overnight Price: $15.00
Canaccord Genuity rates ((EOL)) as Buy (1) –
Energy One delivered first half EBITDA of $9.7m that beat Canaccord Genuity’s estimates. Underlying net profit of $4.2m was marginally lower than expected because of a higher SBP charge.
The company has reiterated its guidance and the broker maintains a Buy rating with a $21.32 target.
This report was published on February 25, 2026.
Target price is $21.32 Current Price is $15.00 Difference: $6.32
If EOL meets the Canaccord Genuity target it will return approximately 42% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
IDX INTEGRAL DIAGNOSTICS LIMITED
Healthcare services – Overnight Price: $2.43
Canaccord Genuity rates ((IDX)) as Buy (1) –
Integral Diagnostics’ 1H26 results were an authentic beat, Canaccord Genuity suggests, but, predictably, the result attracted scrutiny as to what was ‘in’ and what was ‘out’ of underlying earnings – and that drove the stock down.
The broker believes this misses the entire point of the Integral Diagnostics investment, which has always been about the business’ corporate appeal, and the view that large scale consolidation in Australian radiology is inevitable.
That immutable appeal is only amplified by the Capitol Health merger, in Canaccord’s view, which continues to prove that more can be done with less. The combination was and is a structural beneficiary of MRI deregulation.
Trade buyers in healthcare services can and do (typically) pay more than what ASX market participants pay for high quality, well-run healthcare services exposure, Canaccord notes. Target falls to $2.57 from $3.20, Buy retained.
This report was published on March 4, 2026.
Target price is $2.57 Current Price is $2.43 Difference: $0.14
If IDX meets the Canaccord Genuity target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $3.53, suggesting upside of 47.2%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 8.00 cents and EPS of 13.00 cents.
At the last closing share price the estimated dividend yield is 3.29%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.69.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 13.2, implying annual growth of 768.4%.
Current consensus DPS estimate is 7.9, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 18.2.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 9.00 cents and EPS of 15.00 cents.
At the last closing share price the estimated dividend yield is 3.70%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.20.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 15.9, implying annual growth of 20.5%.
Current consensus DPS estimate is 9.5, implying a prospective dividend yield of 4.0%.
Current consensus EPS estimate suggests the PER is 15.1.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Jarden rates ((IDX)) as Buy (1) –
Jarden notes Integral Diagnostics delivered 1H26 operating earnings (EBITDA) of $81.1m, around 3% above the consensus estimate.
The earnings margin came in 60bps ahead of guidance on disciplined labour cost control and favourable modality mix, explain the analysts.
FY26 margin guidance of 21% was unchanged, though seasonality of 47%:53% implies to the broker FY26 earnings of around $172.5m, circa 2% above consensus.
Cash conversion was softer due to timing and higher one-off costs, the broker notes..
FY26-28 EPS forecasts rise by 1.6-5.7% on stronger margins partly offset by tempered revenue growth. Jarden lowers its target price to $3.25 from $3.35 and maintains a Buy rating.
This report was published on February 25, 2026.
Target price is $3.25 Current Price is $2.43 Difference: $0.82
If IDX meets the Jarden target it will return approximately 34% (excluding dividends, fees and charges).
Current consensus price target is $3.53, suggesting upside of 47.2%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 7.50 cents and EPS of 13.40 cents.
At the last closing share price the estimated dividend yield is 3.09%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.13.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 13.2, implying annual growth of 768.4%.
Current consensus DPS estimate is 7.9, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 18.2.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 9.10 cents and EPS of 16.30 cents.
At the last closing share price the estimated dividend yield is 3.74%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.91.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 15.9, implying annual growth of 20.5%.
Current consensus DPS estimate is 9.5, implying a prospective dividend yield of 4.0%.
Current consensus EPS estimate suggests the PER is 15.1.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
INA INGENIA COMMUNITIES GROUP
Aged Care & Seniors – Overnight Price: $4.51
Jarden rates ((INA)) as Buy (1) –
Ingenia Communities delivered 1H26 operating EPS of 15.2c, slightly ahead of Jarden’s 14.9c and the 15.1c consensus estimate.
FY26 EPS guidance of 32.5-34.0c was refined to the top end of the prior range.
Development sales remained strong, in the broker’s view, with 440 deposited or contracted lots at February 20, up 20% on the prior year.
Margins are considered broadly stable despite a -4% decline in development margins to 30% on marketing and mix effects.
Ongoing solid growth is anticipated. Jarden lowers its target price to $5.95 from $6.55 and retains a Buy rating.
This report was published on February 25, 2026.
Target price is $5.95 Current Price is $4.51 Difference: $1.44
If INA meets the Jarden target it will return approximately 32% (excluding dividends, fees and charges).
Current consensus price target is $5.63, suggesting upside of 28.3%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 10.10 cents and EPS of 33.90 cents.
At the last closing share price the estimated dividend yield is 2.24%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.30.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 34.0, implying annual growth of 7.9%.
Current consensus DPS estimate is 9.8, implying a prospective dividend yield of 2.2%.
Current consensus EPS estimate suggests the PER is 12.9.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 10.60 cents and EPS of 37.00 cents.
At the last closing share price the estimated dividend yield is 2.35%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.19.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 37.9, implying annual growth of 11.5%.
Current consensus DPS estimate is 10.3, implying a prospective dividend yield of 2.3%.
Current consensus EPS estimate suggests the PER is 11.6.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
IOD IODM LIMITED
Cloud services – Overnight Price: $0.17
Shaw and Partners rates ((IOD)) as Buy (1) –
IODM has reported 1H26 revenue of $1.8m, up 33% on the prior year, with UK education revenue rising 48% on the prior year. Cash earnings (EBITDA) of -$1.3m improved from -$1.7m, broadly in line with Shaw and Partners’ forecast.
The broker believes UK momentum has reached a tipping point, with 17 universities live and a top-10 or -11 institution onboarding. It’s felt these wins largely de-risk FY27 free cash flow (FCF).
North America discussions around a “one-to-many” model could also accelerate growth, suggests the analyst.
Gross FCF was -$1.5m and net cash stood at $0.6m after converting around $2m of debt to equity, leaving the company debt free, explains the broker.
Shaw maintains a Buy rating and a 23c target price.
This report was published on March 3, 2026.
Target price is $0.23 Current Price is $0.17 Difference: $0.065
If IOD meets the Shaw and Partners target it will return approximately 39% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 55.00.
Forecast for FY27:
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.00 cents.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
IRE IRESS LIMITED
Wealth Management & Investments – Overnight Price: $7.37
Canaccord Genuity rates ((IRE)) as Buy (1) –
Including the contributions from divested businesses, Iress’ total adjusted earnings were 4% ahead of consensus and ahead of the upper band of guidance, Canaccord Genuity notes. Underlying profit was comfortably ahead.
Cash earnings guidance implies a range 4-14% ahead of consensus at the mid-point, the broker notes, while profit guidance implies a range some 12-14% ahead of consensus at the mid-point.
Buy and $11.52 target retained.
This report was published on March 4, 2026.
Target price is $11.52 Current Price is $7.37 Difference: $4.15
If IRE meets the Canaccord Genuity target it will return approximately 56% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
KCN KINGSGATE CONSOLIDATED LIMITED
Gold & Silver – Overnight Price: $7.18
Moelis rates ((KCN)) as Hold (3) –
Kingsgate Consolidated provided a “messy” first half, Moelis notes, with some unexpected significant items. EBITDA was in line with expectations while expenses were missed.
Significantly, to the broker’s surprise, the company decided to pay an interim unfranked dividend of $0.10.
Moelis notes the restart and ramp up have now been executed and the Chatree SE complex is an obvious value lever for the near term. A development decision on Nueva Esperanza is expected in the second half.
Hold rating maintained. The stock is now considered fairly valued and the target is $6.85.
This report was published on February 26, 2026.
Target price is $6.85 Current Price is $7.18 Difference: minus $0.33 (current price is over target).
If KCN meets the Moelis target it will return approximately minus 5% (excluding dividends, fees and charges – negative figures indicate an expected loss).
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 10.00 cents and EPS of 74.90 cents.
At the last closing share price the estimated dividend yield is 1.39%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.59.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 0.00 cents and EPS of 102.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 6.99.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
KLS KELSIAN GROUP LIMITED
Transportation & Logistics – Overnight Price: $4.61
Canaccord Genuity rates ((KLS)) as Buy (1) –
A strong first half result and earnings guidance upgrade from Kelsian Group builds on the improved operational delivery over FY25, Canaccord Genuity suggests.
While every box may not have been ticked within the result, Kelsian’s track record is being laid down, in the broker’s view, albeit appreciation is yet to be conferred from investors.
To Canaccord, the US market venture has proven its class with strong organic growth and sustainable margins and earnings. The broker doesn’t see recent progress as being priced into the valuation and suggests a re-rating is likely as 2026 plays through.
Target rises to $6.00 from $5.80, Buy retained.
This report was published on March 4, 2026.
Target price is $6.00 Current Price is $4.61 Difference: $1.39
If KLS meets the Canaccord Genuity target it will return approximately 30% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 18.00 cents and EPS of 37.00 cents.
At the last closing share price the estimated dividend yield is 3.90%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.46.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 19.00 cents and EPS of 43.60 cents.
At the last closing share price the estimated dividend yield is 4.12%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.57.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MGH MAAS GROUP HOLDINGS LIMITED
Building Products & Services – Overnight Price: $4.86
Canaccord Genuity rates ((MGH)) as Buy (1) –
Maas Group delivered a 1H26 result marginally ahead of Canaccord Genuity’s expectations, but importantly demonstrating growth in the Civil Construction & Hire (CCH) segment and, most notably, the Electrical category.
The broker takes the opportunity to reset forecasts with the pending divestment of Construction Materials.
While Canaccord’s revised forecasts show rapid and material earnings growth for CCH, the broker sees potential for these expectations to be exceeded, particularly with the significant balance sheet capacity for inorganic growth.
Target falls to $4.91 from $5.04, Buy retained.
This report was published on March 4, 2026.
Target price is $4.91 Current Price is $4.86 Difference: $0.05
If MGH meets the Canaccord Genuity target it will return approximately 1% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 7.50 cents and EPS of 27.00 cents.
At the last closing share price the estimated dividend yield is 1.54%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.00.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 10.00 cents and EPS of 26.00 cents.
At the last closing share price the estimated dividend yield is 2.06%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.69.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MMS MCMILLAN SHAKESPEARE LIMITED
Vehicle Leasing & Salary Packaging – Overnight Price: $15.92
Canaccord Genuity rates ((MMS)) as Hold (3) –
McMillan Shakespeare delivered underlying net profit of $50.3m, marginally behind expectations. Canaccord Genuity expects the slightly more difficult operating environment to remain a feature for the rest of FY26 and throughout FY27.
Some volume-related risk exists with the review by the Commonwealth Government into the FBT exemption on BEVs, and automotive market at peak volumes. Forecasts for FY26-28 have been revised down by -2.8-6.2%.
The broker also expects further pressure on NDIS expenditure, which is likely to slow expected growth rates for PSS. No catalyst is envisaged to result in a material re-rating and a Hold rating is maintained. Target is reduced to $17.40 from $18.10.
This report was published on February 23, 2026.
Target price is $17.40 Current Price is $15.92 Difference: $1.48
If MMS meets the Canaccord Genuity target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $18.45, suggesting upside of 19.3%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 127.00 cents and EPS of 149.00 cents.
At the last closing share price the estimated dividend yield is 7.98%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.68.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 151.2, implying annual growth of 10.5%.
Current consensus DPS estimate is 119.4, implying a prospective dividend yield of 7.7%.
Current consensus EPS estimate suggests the PER is 10.2.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 134.00 cents and EPS of 156.00 cents.
At the last closing share price the estimated dividend yield is 8.42%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.21.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 162.6, implying annual growth of 7.5%.
Current consensus DPS estimate is 126.6, implying a prospective dividend yield of 8.2%.
Current consensus EPS estimate suggests the PER is 9.5.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MND MONADELPHOUS GROUP LIMITED
Mining Sector Contracting – Overnight Price: $32.29
Jarden rates ((MND)) as Downgrade to Neutral from Overweight (3) –
Jarden raises its target price for Monadelphous Group to $32.80 from $31.70 after 1H26 profit came in 17% above the consensus estimate. It’s noted net cash of $150m supports balance sheet flexibility.
The broker’s rating is downgraded to Neutral from Overweight given a capex forecast rise which offsets some of the earnings upside.
While remaining below the 20-year average of 8.3%., FY26 earnings (EBITDA) margin guidance of 7.6% exceeds the 6.3% consensus estimate and implies to Jarden a 60bps uplift on FY25,
Core EPS forecasts by 23% in FY26, 18% in FY27 and 16% in FY28, reflecting strong revenue visibility from $1.2bn in recent contract wins.
This report was published on February 24, 2026.
Target price is $32.80 Current Price is $32.29 Difference: $0.51
If MND meets the Jarden target it will return approximately 2% (excluding dividends, fees and charges).
Current consensus price target is $35.41, suggesting upside of 11.5%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 95.50 cents and EPS of 122.80 cents.
At the last closing share price the estimated dividend yield is 2.96%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 26.29.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 126.2, implying annual growth of 48.5%.
Current consensus DPS estimate is 105.9, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 25.2.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 100.50 cents and EPS of 128.00 cents.
At the last closing share price the estimated dividend yield is 3.11%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.23.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 131.0, implying annual growth of 3.8%.
Current consensus DPS estimate is 114.5, implying a prospective dividend yield of 3.6%.
Current consensus EPS estimate suggests the PER is 24.2.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MXI MAXIPARTS LIMITED
Automobiles & Components – Overnight Price: $1.94
Canaccord Genuity rates ((MXI)) as Buy (1) –
MaxiPARTS provided a first half result where earnings were in line with expectations. Margins held steady at 10% with Canaccord Genuity noting organic growth initiatives included the opening of a greenfield site in Kalgoorlie and investment in the Forch sales team.
Management has guided to second half revenue growth and EBITDA margin improvement. The broker considers the business well positioned to leverage existing operations through both organic growth and acquisitions, and benefit from any uptick in economic activity.
A patchy east coast market calls for caution and the broker reduces the target to $2.65 from $2.75. Buy rating maintained.
This report was published on February 23, 2026.
Target price is $2.65 Current Price is $1.94 Difference: $0.71
If MXI meets the Canaccord Genuity target it will return approximately 37% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 8.64 cents and EPS of 19.00 cents.
At the last closing share price the estimated dividend yield is 4.45%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.21.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 9.58 cents and EPS of 21.00 cents.
At the last closing share price the estimated dividend yield is 4.94%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.24.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
NAN NANOSONICS LIMITED
Medical Equipment & Devices – Overnight Price: $3.24
Canaccord Genuity rates ((NAN)) as Buy (1) –
Nanosonics’ 1H26 missed on revenue but it was nothing dramatic, in Canaccord Genuity’s view. Earnings were ahead, FY26 guidance is maintained and CORIS is launching (controlled market release underway).
At current share price, the Trophon-only business appears to be trading at a -15% discount to international med-tech peers. Canaccord can see how CORIS can make Nanosonics seem optically expensive, until it too becomes earnings-generative.
Target rises to $5.55 from $5.43, Buy retained.
This report was published on March 4, 2026.
Target price is $5.55 Current Price is $3.24 Difference: $2.31
If NAN meets the Canaccord Genuity target it will return approximately 71% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 5.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 64.80.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 6.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 54.00.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
NDO NIDO EDUCATION LIMITED
Childcare – Overnight Price: $0.47
Moelis rates ((NDO)) as Buy (1) –
Nido Education provided a 2025 result that was well within guidance, Moelis notes. A number of positives are derived from the outcome, given the company has executed strongly against external headwinds in the child care sector.
While occupancy may be down, the broker believes there are significant signs the business is at or near a trough.
Trading on 9.4x FY26 PE estimates, Moelis considers the stock compelling value and retains a Buy rating. Target is $0.67, reduced from $0.84.
This report was published on February 26, 2026.
Target price is $0.67 Current Price is $0.47 Difference: $0.2
If NDO meets the Moelis target it will return approximately 43% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 3.60 cents and EPS of 5.50 cents.
At the last closing share price the estimated dividend yield is 7.66%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.55.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 4.20 cents and EPS of 6.40 cents.
At the last closing share price the estimated dividend yield is 8.94%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.34.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
NEC NINE ENTERTAINMENT CO. HOLDINGS LIMITED
Print, Radio & TV – Overnight Price: $0.99
Jarden rates ((NEC)) as Overweight (2) –
Nine Entertainment’s interim earnings (EBITDA) of $201m rose 4.5% on the prior year and came in 5% ahead of both Jarden’s forecast and the consensus estimate,.
Television was the main driver, the analysts explain, where EBITDA of $98.9m beat expectations despite a -10% TV ad market. Stan delivered 24% EBITDA growth, though the broker observes subscriber growth is moderating.
Publishing disappointed with earnings of $78m missing the consensus forecast by -5%. The broker’s FY26 earnings forecast is broadly unchanged, though the FY26 profit estimate rises 10% to $126m, below prior consensus on a cautious TV outlook.
Jarden raises its target price to $1.30 from $1.25 and retains a Buy rating.
This report was published on February 25, 2026.
Target price is $1.30 Current Price is $0.99 Difference: $0.305
If NEC meets the Jarden target it will return approximately 31% (excluding dividends, fees and charges).
Current consensus price target is $1.44, suggesting upside of 47.3%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 6.00 cents and EPS of 7.90 cents.
At the last closing share price the estimated dividend yield is 6.03%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.59.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 9.7, implying annual growth of 47.9%.
Current consensus DPS estimate is 7.0, implying a prospective dividend yield of 7.1%.
Current consensus EPS estimate suggests the PER is 10.1.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 6.70 cents and EPS of 9.50 cents.
At the last closing share price the estimated dividend yield is 6.73%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.47.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 11.3, implying annual growth of 16.5%.
Current consensus DPS estimate is 8.4, implying a prospective dividend yield of 8.6%.
Current consensus EPS estimate suggests the PER is 8.7.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
NIC NICKEL INDUSTRIES LIMITED
Nickel – Overnight Price: $0.98
Canaccord Genuity rates ((NIC)) as Buy (1) –
Nickel Industries posted 2025 results that had been largely pre-released in quarterly reports, with revenue and EBITDA in line with estimates. Net profit missed forecasts on higher financing costs and tax charges.
Canaccord Genuity updates modelling and raises its target to $1.10 from $1.05. The broker notes ENC commissioning will begin this quarter and the company has guided to first sales in mid 2026.
2027 is expected to be the first full year of production from the asset.
Buy rating unchanged with the broker envisaging potential for deleveraging over the next three years and the move to a net cash position a key metric for investors to watch.
This report was published on February 23, 2026.
Target price is $1.10 Current Price is $0.98 Difference: $0.115
If NIC meets the Canaccord Genuity target it will return approximately 12% (excluding dividends, fees and charges).
Current consensus price target is $1.24, suggesting upside of 29.2%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 3.05 cents and EPS of 6.10 cents.
At the last closing share price the estimated dividend yield is 3.10%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.15.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 7.5, implying annual growth of N/A.
Current consensus DPS estimate is 4.0, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 12.8.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 3.05 cents and EPS of 7.62 cents.
At the last closing share price the estimated dividend yield is 3.10%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.92.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 22.3, implying annual growth of 197.3%.
Current consensus DPS estimate is 5.6, implying a prospective dividend yield of 5.8%.
Current consensus EPS estimate suggests the PER is 4.3.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
OCL OBJECTIVE CORPORATION LIMITED
IT & Support – Overnight Price: $12.71
Moelis rates ((OCL)) as Buy (1) –
Objective Corp has lowered FY26 recurring revenue growth guidance to 10-14%, which reflects a more cautious approach to the Build roll-out in Australia as well as customer churn in the first half, Moelis notes.
The broker reduces its estimates for FY26 revenue to align with the results, which flows through to lower estimates out to FY28 that are not fully offset by lower costs.
The revisions may be disappointing but Moelis highlights the long-term growth trend, strong margins and enduring customer relationships.
As the share price has corrected alongside the broader software sector, a Buy rating is retained. Target is $18.31.
This report was published on February 26, 2026.
Target price is $18.31 Current Price is $12.71 Difference: $5.6
If OCL meets the Moelis target it will return approximately 44% (excluding dividends, fees and charges).
Current consensus price target is $18.60, suggesting upside of 45.7%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 22.10 cents and EPS of 36.60 cents.
At the last closing share price the estimated dividend yield is 1.74%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 34.73.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 39.2, implying annual growth of 5.5%.
Current consensus DPS estimate is 24.2, implying a prospective dividend yield of 1.9%.
Current consensus EPS estimate suggests the PER is 32.6.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 23.60 cents and EPS of 39.00 cents.
At the last closing share price the estimated dividend yield is 1.86%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 32.59.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 42.7, implying annual growth of 8.9%.
Current consensus DPS estimate is 26.0, implying a prospective dividend yield of 2.0%.
Current consensus EPS estimate suggests the PER is 29.9.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PLY PLAYSIDE STUDIOS LIMITED
Gaming – Overnight Price: $0.28
Canaccord Genuity rates ((PLY)) as Buy (1) –
Playside Studios released a broadly in-line 1H26 result, Canaccord Genuity notes, however, it was overshadowed by the unexpected delay in “Mouse P.I. for Hire” to 16 April (previously 19 March).
Group revenue decreased -28%, largely driven by the -44% decrease in Original IP revenue, coupled with External Projects revenue down -20%.
The company has undergone a material restructuring over the past ten months, Canaccord notes, with headcount now stabilised at 261 which has seen opex/capex decrease -21%.
Given the uncertain nature of the revenue profile for the launch of Mouse, Playside is expecting FY26 revenue to “exceed FY25 with a reduction in operating costs”. Buy and 60c target retained.
This report was published on February 25, 2026.
Target price is $0.60 Current Price is $0.28 Difference: $0.315
If PLY meets the Canaccord Genuity target it will return approximately 111% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 1.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.92.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 1.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.83.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PPS PRAEMIUM LIMITED
Wealth Management & Investments – Overnight Price: $0.74
Canaccord Genuity rates ((PPS)) as Buy (1) –
Canaccord Genuity found the first half earnings from Praemium below estimates, with the driver being average platform margin compression that has reduced to 28 basis points from 30 basis points in FY25.
The net $9m in cash cost savings from technology is expected to be split across both operating and capital expenditure.
The broker expects the annualised run rates of the restructure of the division will fully impact FY27 estimates, with the impact in the second half of FY26 to be largely cash savings on capital expenditure. Buy rating unchanged. Target rises to $1.40 from $1.30.
This report was published on February 24, 2026.
Target price is $1.40 Current Price is $0.74 Difference: $0.655
If PPS meets the Canaccord Genuity target it will return approximately 88% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 2.50 cents and EPS of 5.00 cents.
At the last closing share price the estimated dividend yield is 3.36%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.90.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 3.00 cents and EPS of 7.00 cents.
At the last closing share price the estimated dividend yield is 4.03%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.64.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PRN PERENTI LIMITED
Mining Sector Contracting – Overnight Price: $2.37
Canaccord Genuity rates ((PRN)) as Buy (1) –
Perenti reported reasonable 1H26 results, however Canaccord Genuity now expects a step-up in margins and cash conversion in 2H26 that could be followed by a further increase in earnings across FY27-28 as some key targeted contracts commence.
The commodity price backdrop for Perenti continues to be extremely supportive, the broker suggests, noting that gold now accounts for 76% of group revenue, with copper the second-largest contributor at 8%.
Commentary highlights Drilling is showing signs of a cyclical upswing, while Mining & Tech appears likely to improve. Indications for 2H26 look positive, Canaccord suggests. Target rises to $2.87 from $2.39, Buy retained.
This report was published on March 4, 2026.
Target price is $2.87 Current Price is $2.37 Difference: $0.5
If PRN meets the Canaccord Genuity target it will return approximately 21% (excluding dividends, fees and charges).
Current consensus price target is $2.83, suggesting upside of 23.2%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 7.80 cents and EPS of 21.10 cents.
At the last closing share price the estimated dividend yield is 3.29%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.23.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 21.2, implying annual growth of 64.1%.
Current consensus DPS estimate is 7.7, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 10.8.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 8.90 cents and EPS of 24.10 cents.
At the last closing share price the estimated dividend yield is 3.76%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.83.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 22.6, implying annual growth of 6.6%.
Current consensus DPS estimate is 7.9, implying a prospective dividend yield of 3.4%.
Current consensus EPS estimate suggests the PER is 10.2.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
REG REGIS HEALTHCARE LIMITED
Aged Care & Seniors – Overnight Price: $7.02
Jarden rates ((REG)) as Overweight (2) –
Regis Healthcare defied recent share price weakness by delivering an impressive 1H26 result, Jarden suggests, that beat revenue estimates by 5.8%. Similarly, earnings rose 3.7% year on year, more than offsetting the funding shortfall announced in October.
The highlight of the result was net refundable accommodation deposit (RAD) inflows which brings the RAD liability balance to $2.2bn, which sets Regis up well for the 2% RAD retention that commenced 1 November 2025, Jarden notes.
The broker’s FY26 earnings forecast remains unchanged but ahead of the $130m-135m guidance range, which Regis now expects will come in at the top end. Target rises to $8.50 from $8.30, Overweight retained.
This report was published on February 24, 2026.
Target price is $8.50 Current Price is $7.02 Difference: $1.48
If REG meets the Jarden target it will return approximately 21% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 18.00 cents and EPS of 19.00 cents.
At the last closing share price the estimated dividend yield is 2.56%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 36.95.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 23.20 cents and EPS of 26.60 cents.
At the last closing share price the estimated dividend yield is 3.30%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 26.39.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
REH REECE LIMITED
Furniture & Renovation – Overnight Price: $15.42
Jarden rates ((REH)) as Neutral (3) –
Reece delivered 1H26 earnings 5% ahead of consensus forecasts with the beat characterised by a stronger-than-expected recovery in A&NZ, Jarden notes, where margins rebounded sharply relative to depressed 2H25 levels.
Jarden suggests the outlook now hinges on whether A&NZ competition concerns have peaked, the pace and magnitude of RBA rate hikes, and the earnings contribution from maturing stores.
The broker maintains a Neutral rating, looking for greater clarity on whether the A&NZ margin recovery is structural or volume-driven, and what the mature US store profile implies for medium-term earnings delivery. Target rises to $13.90 from $11.90.
This report was published on March 4, 2026.
Target price is $13.90 Current Price is $15.42 Difference: minus $1.52 (current price is over target).
If REH meets the Jarden target it will return approximately minus 10% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $17.02, suggesting upside of 9.1%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 17.00 cents and EPS of 44.30 cents.
At the last closing share price the estimated dividend yield is 1.10%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 34.81.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 46.3, implying annual growth of -5.9%.
Current consensus DPS estimate is 18.3, implying a prospective dividend yield of 1.2%.
Current consensus EPS estimate suggests the PER is 33.7.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 20.80 cents and EPS of 52.80 cents.
At the last closing share price the estimated dividend yield is 1.35%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 29.20.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 54.9, implying annual growth of 18.6%.
Current consensus DPS estimate is 21.9, implying a prospective dividend yield of 1.4%.
Current consensus EPS estimate suggests the PER is 28.4.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SKC SKYCITY ENTERTAINMENT GROUP LIMITED
Gaming – Overnight Price: $0.69
Jarden rates ((SKC)) as Overweight (2) –
Jarden highlights SkyCity Entertainment delivered a weak but as expected 1H26 result, with underlying earnings (EBITDA) down -28% and NPAT down -68%, reflecting the impact of mandatory carded play in NZ, NZICC pre-opening costs, online investment, and higher Adelaide costs.
Total revenue slipped -2%, with lower gaming revenue partly offset by growth in lower-margin non-gaming segments, while net debt reduced to NZ$594m and the covenant leverage ratio improved to 2.83x.
Management’s FY26 underlying earnings (EBITDA) guidance of NZ$190–210m was maintained, implying 2H skew supported by NZICC visitation and Adelaide cost reduction, with capex slightly lower than prior guidance.
Overweight retained with an unchanged NZ$1.00 target price.
This report was published on February 19, 2026.
Current Price is $0.69. Target price not assessed.
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 3.85 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.93.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of 5.01 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.77.
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SYL SYMAL GROUP LIMITED
Industrial Sector Contractors & Engineers – Overnight Price: $2.52
Jarden rates ((SYL)) as Buy (1) –
Symal Group delivered underlying earnings 6% ahead of Jarden’s forecasts. With earnings guidance maintained for FY26, on a 1H/2H skew of 40/60%, the operating trajectory for the business remains strong for the balance of FY26, the broker suggests, all else equal.
Near-term increases in capex and leases led to higher D&A and interest costs, which will carry through to 2H26. The share price decline on its result delivery (-24%) appears overdone to Jarden, as capex and lease investment should underpin earnings growth in FY27.
Target falls to $3.00 from $3.45 on increased capex, Buy retained.
This report was published on March 4, 2026.
Target price is $3.00 Current Price is $2.52 Difference: $0.48
If SYL meets the Jarden target it will return approximately 19% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 9.50 cents and EPS of 20.50 cents.
At the last closing share price the estimated dividend yield is 3.77%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.29.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 11.30 cents and EPS of 24.00 cents.
At the last closing share price the estimated dividend yield is 4.48%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.50.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
THL TOURISM HOLDINGS LIMITED
Travel, Leisure & Tourism – Overnight Price: $2.15
Jarden rates ((THL)) as Overweight (2) –
Tourism Holdings delivered a result in line with Jarden, with normalised profit up 11% year on year.
This marked a material improvement from a very weak 2H25, while a return to providing full year earnings guidance reflects increasing confidence that the business has indeed passed an inflection point, Jarden notes.
Notwithstanding a challenging US market where international tourism demand is weak, management views overall operating conditions as positive, with global tourism in “growth mode”.
Tourism Holdings has undertaken a number of cost out and other strategic initiatives over recent periods, which Jarden expects will provide a solid platform for meaningful earnings growth as volumes recover.
Target rises to NZ$3.59 from NZ$3.49, Overweight retained.
This report was published on February 24, 2026.
Current Price is $2.15. Target price not assessed.
Current consensus price target is $3.29, suggesting upside of 53.0%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 8.95 cents and EPS of 18.26 cents.
At the last closing share price the estimated dividend yield is 4.16%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.78.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 17.9, implying annual growth of N/A.
Current consensus DPS estimate is 7.8, implying a prospective dividend yield of 3.6%.
Current consensus EPS estimate suggests the PER is 12.0.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 11.64 cents and EPS of 26.49 cents.
At the last closing share price the estimated dividend yield is 5.41%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.12.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 27.3, implying annual growth of 52.5%.
Current consensus DPS estimate is 11.6, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 7.9.
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TLX TELIX PHARMACEUTICALS LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $9.87
Canaccord Genuity rates ((TLX)) as Buy (1) –
Telix Pharmaceuticals’ 2026 revenue guidance (18-20% growth on 2025) is well ahead of consensus.
Canaccord Genuity has a Buy rating on Telix, expecting a string of announcements could reverse the principal drivers of poor sentiment and short interest in the stock.
2025 revenue result was broadly known via quarterlies. Opex was lower than expected but Canaccord will continue to model nominal earnings to accommodate Telix’s infrastructure build over FY26-27.
Target unchanged at $28.50.
This report was published on March 4, 2026.
Target price is $28.50 Current Price is $9.87 Difference: $18.63
If TLX meets the Canaccord Genuity target it will return approximately 189% (excluding dividends, fees and charges).
Current consensus price target is $24.55, suggesting upside of 154.9%(ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is -10.7, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY27:
Current consensus EPS estimate is 19.8, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 48.6.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TYR TYRO PAYMENTS LIMITED
Business & Consumer Credit – Overnight Price: $0.81
Canaccord Genuity rates ((TYR)) as Buy (1) –
Tyro Payments delivered EBITDA in the first half that beat Canaccord Genuity’s estimates amid ongoing growth in core payments TTV and control of costs. The company has maintained its FY26 gross profit guidance of $230-240m.
The broker expects the conclusions and implementation timeline from the RBA this month regarding proposed changes to surcharging and interchange caps.
Given what the central bank has previously flagged, if implemented, the broker envisages a large step-down in the company’s cost of goods sold (COGS) and an uplift in gross profit margins.
This would mean a large margin opportunity accrues to merchant acquirers such as Tyro Payments, which then have a choice of holding margin or passing it on to customers. Buy rating. Target is reduced to $1.60 from $1.70.
This report was published on February 25, 2026.
Target price is $1.60 Current Price is $0.81 Difference: $0.785
If TYR meets the Canaccord Genuity target it will return approximately 96% (excluding dividends, fees and charges).
Current consensus price target is $1.22, suggesting upside of 50.3%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 6.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.58.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 4.3, implying annual growth of 26.8%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 18.8.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 7.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.64.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 4.6, implying annual growth of 7.0%.
Current consensus DPS estimate is 0.7, implying a prospective dividend yield of 0.9%.
Current consensus EPS estimate suggests the PER is 17.6.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
VAU VAULT MINERALS LIMITED
Gold & Silver – Overnight Price: $5.75
Moelis rates ((VAU)) as Buy (1) –
First half results from Vault Minerals were largely in line with expectations, although higher D&A drove a miss at the underlying net profit level, Moelis notes.
The interim dividend of seven cents, unfranked, was a surprise, without any additional direction to investors that this will be recurring. The broker asks, does that make it a special dividend?
Few changes are made to modelling and, while incorporating the dividend, Moelis chose not to include any further payments.
The business is considered “perfectly positioned” for a slow and steady market with assets that are largely unhedged and heavy lifting on the capital program at King of the Hills all but completed.
Buy rating. Target is $7.60 and unchanged.
This report was published on February 26, 2026.
Target price is $7.60 Current Price is $5.75 Difference: $1.85
If VAU meets the Moelis target it will return approximately 32% (excluding dividends, fees and charges).
Current consensus price target is $7.62, suggesting upside of 35.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 7.00 cents and EPS of 18.50 cents.
At the last closing share price the estimated dividend yield is 1.22%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 31.08.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 48.9, implying annual growth of 115.9%.
Current consensus DPS estimate is 8.0, implying a prospective dividend yield of 1.4%.
Current consensus EPS estimate suggests the PER is 11.5.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 0.00 cents and EPS of 74.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.75.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 75.2, implying annual growth of 53.8%.
Current consensus DPS estimate is 9.7, implying a prospective dividend yield of 1.7%.
Current consensus EPS estimate suggests the PER is 7.5.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
VGL VISTA GROUP INTERNATIONAL LIMITED
Software & Services – Overnight Price: $1.53
Shaw and Partners rates ((VGL)) as Buy (1) –
Vista Group reported FY25 revenue of NZ$164m, up 10% on the prior year but below guidance of NZ$167-173m and Shaw and Partners’ NZ$167m forecast.
Earnings (EBITDA) of NZ$28.2m rose 31% with a 17% margin and gross free cash flow (FCF) of NZ$2.1m; all in line with the broker’s expectations.
The analyst highlights cloud migration is accelerating, with 724 sites live and guidance for 1,300 in FY26, and believes the pathway to FCF break-even in FY27 is increasingly visible.
Long-term FY30 targets were re-iterated, implying ARR of NZ$315m and EBITDA margins of 33-37%, which the broker argues signals a material lift in FCF to around NZ$75m by FY31.
Shaw maintains a Buy rating and lowers its target price to $3.70 from $4.10.
This report was published on March 3, 2026.
Target price is $3.70 Current Price is $1.53 Difference: $2.17
If VGL meets the Shaw and Partners target it will return approximately 142% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 1.25 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 122.11.
Forecast for FY27:
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 2.95 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 51.79.
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
VYS VYSARN LIMITED
Industrial Sector Contractors & Engineers – Overnight Price: $0.80
Canaccord Genuity rates ((VYS)) as Buy (1) –
Vysarn increased pre-tax profit by 92% in the first half, which was ahead of Canaccord Genuity’s estimates. The company continues to target FY26 pre-tax profit of $20m based on current work in hand and anticipated awards across multiple segments.
The broker notes significant growth was achieved despite some residual timing headwinds in technology and investment.
Demand continues to grow amid increased need for sustainable water management solutions, facilitating the company’s efforts to diversify income across geographic regions and industry sectors. Target is raised to $0.95 from $0.74 and a Buy rating is retained.
This report was published on February 24, 2026.
Target price is $0.95 Current Price is $0.80 Difference: $0.15
If VYS meets the Canaccord Genuity target it will return approximately 19% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 3.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 26.67.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 3.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 26.67.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
WPR WAYPOINT REIT LIMITED
REITs – Overnight Price: $2.49
Moelis rates ((WPR)) as Buy (1) –
Waypoint REIT posted 2025 distributable earnings of 16.64c per security, in line with upgraded guidance. Moelis notes six non-core assets were sold in the half for $40.6m at an average passing yield of 7.9%.
The Viva OTR roll-out is progressing with 17 sites converted to date and landlord consent provided for 40.
The broker observes the company’s capital recycling continues to improve the quality of the portfolio with regional exposure now around 8% and increasingly weighted to metro and highway assets. Buy rating and $2.99 target maintained.
This report was published on February 26, 2026.
Target price is $2.99 Current Price is $2.49 Difference: $0.5
If WPR meets the Moelis target it will return approximately 20% (excluding dividends, fees and charges).
Current consensus price target is $2.58, suggesting upside of 2.5%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 17.10 cents and EPS of 17.10 cents.
At the last closing share price the estimated dividend yield is 6.87%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.56.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 17.0, implying annual growth of -43.7%.
Current consensus DPS estimate is 16.8, implying a prospective dividend yield of 6.7%.
Current consensus EPS estimate suggests the PER is 14.8.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 17.60 cents and EPS of 17.60 cents.
At the last closing share price the estimated dividend yield is 7.07%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.15.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is N/A, implying annual growth of N/A.
Current consensus DPS estimate is 16.8, implying a prospective dividend yield of 6.7%.
Current consensus EPS estimate suggests the PER is N/A.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
<span style="
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: AMA - AMA GROUP LIMITED
For more info SHARE ANALYSIS: AMI - AURELIA METALS LIMITED
For more info SHARE ANALYSIS: AR1 - AUSTRAL RESOURCES AUSTRALIA LIMITED
For more info SHARE ANALYSIS: ARB - ARB CORPORATION LIMITED
For more info SHARE ANALYSIS: ASG - AUTOSPORTS GROUP LIMITED
For more info SHARE ANALYSIS: AUB - AUB GROUP LIMITED
For more info SHARE ANALYSIS: BC8 - BLACK CAT SYNDICATE LIMITED
For more info SHARE ANALYSIS: CUP - COUNT LIMITED
For more info SHARE ANALYSIS: CXL - CALIX LIMITED
For more info SHARE ANALYSIS: EMR - EMERALD RESOURCES NL
For more info SHARE ANALYSIS: EOL - ENERGY ONE LIMITED
For more info SHARE ANALYSIS: IDX - INTEGRAL DIAGNOSTICS LIMITED
For more info SHARE ANALYSIS: INA - INGENIA COMMUNITIES GROUP
For more info SHARE ANALYSIS: IOD - IODM LIMITED
For more info SHARE ANALYSIS: IRE - IRESS LIMITED
For more info SHARE ANALYSIS: KCN - KINGSGATE CONSOLIDATED LIMITED
For more info SHARE ANALYSIS: KLS - KELSIAN GROUP LIMITED
For more info SHARE ANALYSIS: MGH - MAAS GROUP HOLDINGS LIMITED
For more info SHARE ANALYSIS: MMS - MCMILLAN SHAKESPEARE LIMITED
For more info SHARE ANALYSIS: MND - MONADELPHOUS GROUP LIMITED
For more info SHARE ANALYSIS: MXI - MAXIPARTS LIMITED
For more info SHARE ANALYSIS: NAN - NANOSONICS LIMITED
For more info SHARE ANALYSIS: NDO - NIDO EDUCATION LIMITED
For more info SHARE ANALYSIS: NEC - NINE ENTERTAINMENT CO. HOLDINGS LIMITED
For more info SHARE ANALYSIS: NIC - NICKEL INDUSTRIES LIMITED
For more info SHARE ANALYSIS: OCL - OBJECTIVE CORPORATION LIMITED
For more info SHARE ANALYSIS: PLY - PLAYSIDE STUDIOS LIMITED
For more info SHARE ANALYSIS: PPS - PRAEMIUM LIMITED
For more info SHARE ANALYSIS: PRN - PERENTI LIMITED
For more info SHARE ANALYSIS: REG - REGIS HEALTHCARE LIMITED
For more info SHARE ANALYSIS: REH - REECE LIMITED
For more info SHARE ANALYSIS: SKC - SKYCITY ENTERTAINMENT GROUP LIMITED
For more info SHARE ANALYSIS: SYL - SYMAL GROUP LIMITED
For more info SHARE ANALYSIS: THL - TOURISM HOLDINGS LIMITED
For more info SHARE ANALYSIS: TLX - TELIX PHARMACEUTICALS LIMITED
For more info SHARE ANALYSIS: TYR - TYRO PAYMENTS LIMITED
For more info SHARE ANALYSIS: VAU - VAULT MINERALS LIMITED
For more info SHARE ANALYSIS: VGL - VISTA GROUP INTERNATIONAL LIMITED
For more info SHARE ANALYSIS: VYS - VYSARN LIMITED
For more info SHARE ANALYSIS: WPR - WAYPOINT REIT LIMITED

